As shown in Figures 2A,B, SCG3 expression was significantly lower in grade IV gliomas (GBMs) than grade II/III gliomas at both transcriptional and protein levels, whereas no difference was observed between grade II and III gliomas. Here, SCG3 is linked to glioma.